United Therapeutics Corp (UTHR)
262.33
+4.22
(+1.63%)
USD |
NASDAQ |
May 03, 16:00
262.33
0.00 (0.00%)
After-Hours: 20:00
United Therapeutics Cash from Financing (Quarterly): -1.068B for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -1.068B |
| December 31, 2023 | -92.80M |
| September 30, 2023 | 7.60M |
| June 30, 2023 | 24.70M |
| March 31, 2023 | 48.60M |
| December 31, 2022 | 55.50M |
| September 30, 2022 | 7.00M |
| June 30, 2022 | 23.90M |
| March 31, 2022 | -11.00M |
| December 31, 2021 | 7.50M |
| September 30, 2021 | 16.60M |
| June 30, 2021 | 10.60M |
| March 31, 2021 | 10.10M |
| December 31, 2020 | 6.10M |
| September 30, 2020 | 5.60M |
| June 30, 2020 | 21.60M |
| March 31, 2020 | -50.20M |
| December 31, 2019 | -150.00M |
| September 30, 2019 | -48.30M |
| June 30, 2019 | 0.40M |
| March 31, 2019 | 809.10M |
| December 31, 2018 | 0.10M |
| September 30, 2018 | 2.40M |
| June 30, 2018 | -6.80M |
| March 31, 2018 | 10.60M |
| Date | Value |
|---|---|
| December 31, 2017 | 1.80M |
| September 30, 2017 | 3.50M |
| June 30, 2017 | 3.60M |
| March 31, 2017 | 34.40M |
| December 31, 2016 | -101.70M |
| September 30, 2016 | -132.30M |
| June 30, 2016 | -140.50M |
| March 31, 2016 | -123.20M |
| December 31, 2015 | -13.80M |
| September 30, 2015 | -41.90M |
| June 30, 2015 | -245.70M |
| March 31, 2015 | -145.60M |
| December 31, 2014 | -239.34M |
| September 30, 2014 | -72.58M |
| June 30, 2014 | -182.76M |
| March 31, 2014 | -81.92M |
| December 31, 2013 | 8.886M |
| September 30, 2013 | 14.39M |
| June 30, 2013 | -29.08M |
| March 31, 2013 | 0.694M |
| December 31, 2012 | -49.99M |
| September 30, 2012 | -34.95M |
| June 30, 2012 | -86.33M |
| March 31, 2012 | 2.128M |
| December 31, 2011 | -248.51M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-1.068B
Minimum
Mar 2024
55.50M
Maximum
Dec 2022
-58.72M
Average
7.25M
Median
Cash from Financing (Quarterly) Benchmarks
| Liquidia Corp | 23.64M |
| Esperion Therapeutics Inc | 4.471M |
| Vertex Pharmaceuticals Inc | -119.80M |
| Heron Therapeutics Inc | 0.199M |
| Aldeyra Therapeutics Inc | -1.012M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 376.50M |
| Cash from Investing (Quarterly) | 735.30M |
| Free Cash Flow | 752.40M |
| Free Cash Flow Per Share (Quarterly) | 6.807 |
| Free Cash Flow to Equity (Quarterly) | 438.30M |
| Free Cash Flow to Firm (Quarterly) | 338.30M |
| Free Cash Flow Yield | 5.77% |